Is HURA or ICU more undervalued in 2026?

CirclFi compares TuHURA Biosciences, Inc. (HURA) and SeaStar Medical Holding Corpora (ICU) using 13 institutional-grade valuation models. HURA has a Quality of Company score of 2.9/10 while ICU scores 5.9/10.

Which is a better buy — HURA or ICU?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do HURA and ICU valuations compare?

HURA at $2.35 and ICU at $3.66 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

HURA vs ICU Valuation Comparison 2026 — Intrinsic Value Analysis

HURA

Biotechnology

TuHURA Biosciences, Inc.

Quality

2.9

out of 10

Value Trap

WARN

Price

$2.35

Last close

Models

7/13

Active

ICU

Biotechnology

SeaStar Medical Holding Corpora

Quality

5.9

out of 10

Value Trap

SAFE

Price

$3.66

Last close

Models

11/13

Active

Model-by-Model Comparison

Model	Type	HURA Fair Value	HURA Upside	ICU Fair Value	ICU Upside
Bayesian DCF	Intrinsic	$0.31	-87.0%	$2.26	-38.3%
Earnings Power Value	Intrinsic	—	—	$3.83	-12.3%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$1.06	-55.1%	$5.56	+52.0%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for HURA vs ICU — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

HURA vs ICU — Which Stock Is More Undervalued?

ICU scores higher with a 5.9/10 quality rating vs HURA's 2.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing TuHURA Biosciences, Inc. (HURA) and SeaStar Medical Holding Corpora (ICU) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

HURA currently trades at $2.35 with a QOC of 2.9/10, while ICU trades at $3.66 with a QOC of 5.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).